iRhythm Holdings, Inc. Announces Settlement Agreement in Securities Class Action Litigation
Key Points:
- iRhythm Holdings, Inc. (NASDAQ: IRTC) has entered into a binding Stipulation and Agreement of Settlement to fully resolve a previously-disclosed putative class action securities litigation.
- The litigation, titled Glazing Employers and Glaziers’ Union Local #27 Pension and Retirement Fund, on behalf of itself and all others similarly situated, v. iRhythm Technologies, Inc., Case No. 3:24-cv-706-JSC, was pending in the United States District Court for the Northern District of California.
- The settlement agreement covers claims against iRhythm Technologies, Inc. (a wholly owned subsidiary) and Quentin Blackford, Chief Executive Officer and President.
- The settlement is subject to court approval. The lead plaintiff has filed a motion for preliminary approval.
- The company expects that a majority of the settlement payment will be covered by its directors and officers’ insurance policies.
- This settlement does not resolve previously-disclosed stockholder derivative lawsuits brought by stockholders on behalf of iRhythm Technologies, Inc.
- The company does not expect the settlement agreement to impact its adjusted EBITDA, adjusted net income (loss), or adjusted operating expenses.
Detailed Analysis for Investors
On June 3, 2026, iRhythm Holdings, Inc. announced that its subsidiary, iRhythm Technologies, Inc., entered into a binding settlement agreement to resolve a major class action lawsuit regarding alleged securities violations. The case was brought by a pension and retirement fund on behalf of itself and other similarly situated shareholders, and named both the company and its CEO, Quentin Blackford, as defendants.
The settlement is a significant step for iRhythm, removing a substantial legal overhang. While the proposed settlement is subject to court approval, the lead plaintiff has already moved for preliminary approval. If granted, the settlement will bring closure to a litigation that could have posed risks to the company’s reputation and financial standing.
Importantly, iRhythm Holdings expects that most of the monetary settlement will be covered by its directors and officers’ insurance policies, minimizing direct financial impact. The company explicitly states that the settlement is not anticipated to affect its key financial metrics, including adjusted EBITDA, adjusted net income (loss), or adjusted operating expenses, as these metrics exclude non-GAAP items related to the settlement.
However, the settlement does not resolve several stockholder derivative lawsuits that have been brought by shareholders on behalf of the company. These remain a potential risk, but are not included in this agreement.
Potential Share Price Impact
- The resolution of the class action litigation may be viewed positively by shareholders and investors as it removes uncertainty and potential liability.
- With insurance covering the majority of the settlement payment, the company’s cash position and future earnings may be largely unaffected.
- The continued existence of unresolved derivative lawsuits may temper investor optimism, but the company is now free from the specific class action litigation risk.
- Forward-looking statements indicate that the company does not expect the settlement to materially affect its core financial metrics.
What Shareholders Should Know
- This settlement addresses a key risk factor that has been disclosed previously and is now being resolved.
- The company has been transparent about the process and financial expectations, including insurance coverage and no expected impact on adjusted financials.
- Investors should monitor the court approval process, as the settlement is not yet final.
- The unresolved stockholder derivative lawsuits remain as ongoing legal matters.
Forward-Looking Statements
The company cautions that forward-looking statements regarding the settlement, insurance coverage, and impact on financials are subject to risks and uncertainties. Court approval and insurance coverage are not guaranteed, and investors should refer to the company’s most recent filings for further risk factors.
Disclaimer: This article is based on public filings made by iRhythm Holdings, Inc. and may contain forward-looking statements subject to risks and uncertainties. This is not investment advice. Please consult official SEC filings and your financial advisor before making investment decisions.
